New

LACOSAMIDE ORAL SOLUTION

Overview

NDC #
Strength
Product/Case Size
NDC #
00121-0992-95
Strength
50 mg/5 mL
Product/Case Size
5 mL/10 cs
NDC #
00121-1984-95
Strength
100 mg/10 mL
Product/Case Size
10 mL/10 cs
NDC #
66689-109-10
Strength
10 mg/mL
Product/Case Size
15 mL/10 cs
NDC #
66689-110-10
Strength
10 mg/mL
Product/Case Size
20 mL/10 cs
00121-0992-95
50 mg/5 mL
5 mL/10 cs
00121-1984-95
100 mg/10 mL
10 mL/10 cs
66689-109-10
10 mg/mL
15 mL/10 cs
66689-110-10
10 mg/mL
20 mL/10 cs

Wholesale Ordering

NDC #
AmerisourceBergen
Cardinal
McKesson
Morris Dickson
NDC #
00121-0992-95
AmerisourceBergen
10274586
Cardinal
5813829
McKesson
2656155
Morris Dickson
188623
NDC #
00121-1984-95
AmerisourceBergen
10275071
Cardinal
5813837
McKesson
2656163
Morris Dickson
188631
NDC #
66689-109-10
AmerisourceBergen
10263282
Cardinal
5754072
McKesson
2369569
Morris Dickson
137984
NDC #
66689-110-10
AmerisourceBergen
10263018
Cardinal
5754080
McKesson
2369577
Morris Dickson
138032
00121-0992-95
10274586
5813829
2656155
188623
00121-1984-95
10275071
5813837
2656163
188631
66689-109-10
10263282
5754072
2369569
137984
66689-110-10
10263018
5754080
2369577
138032

Key Info

Compared to: Vimpat®

Free From:

N/A

Rx or OTC:

Rx

Flavor:

Strawberry-flavored

Storage & Handling:

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Do not freeze lacosamide oral solution. Discard any unused lacosamide oral solution remaining after seven (7) weeks of first opening the package.

Indications:

  • Treatment of partial-onset seizures in patients 1 month of age and older
  • As adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older


Please see full Prescribing Information for more information.